Recherche
-
Safety and Immunogenicity of Hpv Vaccination in Immunocompromised Girls: The Primavera Clinical Trial (Nct 01687192)
Communication dans un congrès -
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
(Science Immunology. vol. 6, n° 62, 2021-08-19)Article de revueLibre accès -
Costs and economies of scale in repeated home-based HIV counselling and testing: Evidence from the ANRS 12249 treatment as prevention trial in South Africa
(Social Science and Medicine. vol. 305, 2022-07)Article de revueLibre accès -
Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study
(The Lancet Regional Health - Europe. vol. 17, 2022-06)Article de revueLibre accès -
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective
(Cancers. vol. 13, n° 23, 2021-12-05)Article de revueLibre accès -
Barriers to early diagnosis of cervical cancer: a mixed-method study in Cote d'Ivoire, West Africa
(BMC Women's Health. vol. 23, n° 1, 2023-03-27)Article de revueLibre accès -
Therapeutic Patient Education for Fibromyalgia during Spa Therapy: The FiETT Randomized Controlled Trial
(International Journal of Environmental Research and Public Health. vol. 19, n° 8, 2022-04-11)Article de revueLibre accès -
Features of inflammatory heart reactions following mRNA COVID-19 vaccination at a global level
(Clinical Pharmacology and Therapeutics, 2021-12-03)Article de revueLibre accès -
Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children
(Kidney International. vol. 103, n° 6, pp. 1193-1198, 2023-06)Article de revueLibre accès -
Analysis of Maternal Postnatal Depression, Socioeconomic Factors, and Offspring Internalizing Symptoms in a Longitudinal Cohort in South Africa
(JAMA Network Open. vol. 4, n° 8, pp. e2121667, 2021-08-02)Article de revueLibre accès